Workflow
直击进博会 蔡司大中华区总裁兼首席执行官费铭远:不断加大在华投资力度,扩大本土布局
Zhong Guo Jing Ying Bao·2025-11-09 12:58

Core Insights - Zeiss has been participating in the China International Import Expo (CIIE) for eight consecutive years, marking its 68th year in China, highlighting the significance of the number "8" in Chinese culture [1][2] - The company is increasing its investment and presence in China, launching a comprehensive headquarters project to integrate operations, sales, R&D, production, and supply chain functions [1][5] Investment and Market Strategy - Zeiss views China as an ideal business destination due to its large market, open business environment, favorable policies, abundant talent and resources, and developed supply chain [1][5] - The company has experienced a sixfold revenue growth in the past decade, with over 7,000 employees in China, and has been recognized as a "Top Employer" for six consecutive years [6][6] Innovation and Product Development - At the CIIE, Zeiss showcased over 60 innovative solutions across four business areas: medical technology, consumer optics, industrial quality and research, and semiconductor manufacturing technology [2][4] - Notable product launches included the ARTEVO 750 digital navigation surgical microscope, which features a 21% improvement in optical resolution, and the PENTERO 800 S, the first high-end surgical microscope developed in China [4][5] Collaboration and Local Integration - Zeiss is deepening its integration into the local ecosystem by establishing R&D centers in Shanghai, Suzhou, and Guangzhou, and has obtained 89 patents in China [7][8] - The company is forming strategic partnerships with local firms, such as SF Express and vivo, to enhance its supply chain ecosystem and accelerate innovation [8][8] Future Outlook - The new comprehensive headquarters project is Zeiss's largest single investment in China, aimed at enhancing service capabilities and acting as a global innovation center [6][6] - The company is committed to supporting China's "Healthy China 2030" initiative through its medical and vision care solutions, aligning its technological advantages with China's strategic goals [6][6]